Status:
COMPLETED
Multicentric, Open Label With Retrospective Inclusion and Follow-up of Acetabular Prothetic Implant "Polymax"
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
Total replacement of hip joint is one of the most important medical innovations of the twentieth century. More than 100,000 hip replacements are being laid each year in France. Improved fixation, red...
Eligibility Criteria
Inclusion
- Patient suffering from hip disease: primary or secondary hip osteoarthritis or osteonecrosis.
- Patient having been implanted with a POLYMAX implant;
- Patient having agreed to participate in a follow-up 5 years;
- Patient who have accepted the use of their data in the context of this study.
- Patient having pre-operative and post-operative data
Exclusion
- Pre or post-operative Partial data
- Patients not available for follow up at 2 and 5 years ..
- Metabolic disease or autoimmune witch may interfere with bone growth not allowing the indication of a prosthesis without cement,
- Mental disorder or disease of proven behavior.
- Severe osteoporosis,
- Direct or indirect bone irradiation
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
181 Patients enrolled
Trial Details
Trial ID
NCT02826187
Start Date
July 1 2014
End Date
July 1 2022
Last Update
June 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Grégoire Hospital
Saint-Grégoire, France, 56816
2
Purpan Hospital
Toulouse, France, 31059